Built-In, Not Bolted On: The Case for Native Digital Adoption in Life Sciences Software

1. The Stakes: Why Digital Adoption Matters Now

1.1 The Explosion of Enterprise Software — and Its Discontents

The modern enterprise runs on software. The average large organization now operates more than 100 SaaS applications, and enterprise software spend is expected to exceed $443 billion globally in 2025, growing toward $1.15 trillion by 2035. In life sciences and pharmaceutical organizations specifically, the software portfolio has expanded dramatically: quality management systems, document management platforms, laboratory information systems, clinical trial management tools, training and compliance platforms, ERP and CRM solutions — all layered atop one another, each with its own interface, workflows, and learning requirements.

A 2025 report from Freshworks found that organizational and software complexity drains an average of 7% of annual revenue and that employees lose nearly seven hours every week to complicated processes and fragmented tools. Separately, McKinsey data indicates that 70% of digital transformation initiatives fail, with employee resistance and low adoption cited as the primary drivers.

1.2 Training Doesn’t Scale — Readiness Must Be Continuous

For decades, the standard response to this challenge has been training. The results are predictably inconsistent. One-time training cannot account for software updates, role changes, process evolution, or the natural decay of knowledge over time. Research from Userlane found that users interact with only 40% of the features available in the enterprise software they are required to use, and that 60% of software license fees generate no return on investment.

1.3 The Business Case for Adoption Is No Longer Optional

Enterprise companies now spend an average of $4,830 per employee per year on SaaS alone. Studies consistently show that roughly 30% of software licenses go unused entirely, and another 8% see engagement less than once per month. Poor adoption also degrades data quality — organizations with poor enterprise software adoption experience data quality degradation of 40–60% compared to peers with strong adoption programs. In regulated environments, data integrity is the foundation of compliance, regulatory submission validity, and patient safety.

2. The ROI Case: Value, Performance, Satisfaction

2.1 Where Value Goes to Die

The return on investment from enterprise software has always been contingent on utilization. The Freshworks Cost of Complexity Report found that 53% of companies have not received the ROI they planned from their software investments, and that 34% experience revenue leakage from software delays and missed opportunities. When a quality manager navigates an eQMS inefficiently, it introduces delays in batch review, gaps in deviation management, and potential CAPA documentation failures.

2.2 Accuracy and Performance: The Downstream Consequences

One of the most underappreciated consequences of low user proficiency is its effect on data accuracy. Under FDA 21 CFR Part 11 and EMA Annex 11, organizations must demonstrate that electronic records are accurate, complete, attributable, and traceable. An eQMS or eTMF that is poorly adopted becomes a compliance liability even if the platform itself is technically validated.

2.3 Organizational ROI Revisited

Userlane data from a multinational enterprise implementation showed a 50% reduction in employee onboarding time and a 40% cut in IT training costs. Manufacturers that have automated batch record processes with supporting user guidance have achieved batch record accuracy rates above 95%, compared to industry averages in the low 80s. A 2025 Freshworks survey found that 60% of employees are at least somewhat likely to leave their organizations within the next year, with complicated processes and poor software experience among the top cited drivers.

2.4 What “Proficient from Day One” Is Actually Worth

Userlane research found that employees lose more than 22 minutes per day struggling with software-related friction — equivalent to more than two full working weeks per year. At an average annual salary of $80,000, that represents approximately $3,700 per employee per year in lost productive time. For an organization of 1,000 employees, that is $3.7 million annually.

3. The Limitations of Overlay-Only Models

3.1 What Current Digital Adoption Platforms Do Well

The current generation of digital adoption platforms — Userlane, Whatfix, WalkMe (now part of SAP), Pendo, and others — represents a genuine and valuable advance over traditional training paradigms. IDC predicts that 80% of G1000 organizations will be using DAPs by 2027 to mitigate technical skill shortages, signaling mainstream recognition of their value.

3.2 The Structural Problem with Add-On Layers

Yet the overlay model carries structural limitations that become increasingly visible at scale. The most fundamental is the adoption-of-the-adoption-tool problem. A DAP is itself a complex enterprise software deployment requiring its own implementation, content creation cycle, and organizational ownership.

3.3 Experience Fragmentation

The overlay is not native to the application. It does not share the application’s data model, user identity infrastructure, or workflow logic at the deepest level. The guidance it provides is based on UI patterns and triggered events — powerful, but not the same as guidance informed by the application’s own knowledge of what the user is trying to accomplish.

4. The Integration Imperative: What Native Adoption Looks Like

4.1 The GenAI Precedent — and What It Teaches Us

The trajectory of generative AI in enterprise software is instructive. In 2021 and 2022, generative AI was primarily a standalone capability. Then the major enterprise software vendors moved: Salesforce embedded Einstein AI and Agentforce, SAP integrated Joule natively, Microsoft embedded Copilot across the 365 suite. Within two to three years, generative AI had transitioned from an add-on category to a standard feature set in every major enterprise platform. Digital adoption is foundational in exactly the same way.

4.2 What Native Digital Adoption Would Look Like in Practice

At its fullest expression, native digital adoption means the software platform itself takes responsibility for user proficiency as a product-level commitment: role-aware onboarding flows built into the platform’s first-run experience; dynamic help systems that know where the user is in a workflow; proactive error prevention that engages before errors propagate; and continuous usage analytics that feed back into the product improvement cycle.

4.3 The Life Sciences Software Opportunity

For software providers serving pharmaceutical, biotechnology, and medical device organizations, the case for native adoption features is especially compelling. An eQMS user who enters deviation data incorrectly is not just less productive — they are creating a 21 CFR Part 11 audit liability.

5. A Partner Perspective: Conversation with Userlane

5.1 About Userlane

Userlane is a market-leading digital adoption platform recognized by IDC, Gartner, and Everest Group for its capabilities in enterprise software adoption, lifecycle management, and optimization. Userlane was named a Leader in the IDC MarketScape: Worldwide Digital Adoption Platform Vendor 2024 Assessment.

5.2 What the Userlane Perspective Surfaces

The adoption gap is widening, not narrowing. As enterprise software has grown more powerful, it has also grown more complex. Measurement is the missing link — organizations frequently deploy DAPs without establishing clear success metrics upfront. The native integration argument resonates, while the overlay model will remain relevant across the long tail of enterprise software.

5.3 What “Life Sciences Ready” Means for a DAP

Guidance content in a regulated environment is, in effect, a procedural document. It must be accurate, version-controlled, reviewed for regulatory alignment, and updated in lockstep with process changes. An organization whose SOPs change after a regulatory inspection but whose DAP guidance content still reflects the pre-inspection procedure has a compliance gap.

6. Measuring Success: A Practical Metrics Framework

6.1 Why Most Organizations Are Measuring the Wrong Things

The most common metrics used to assess digital adoption are lagging indicators: support ticket volumes, training completion rates, and periodic user surveys. A robust adoption metrics framework leads with forward-looking, behavior-based indicators. Userlane’s HEART framework — tracking Happiness, Engagement, Adoption, Retention, and Task Success — provides a useful structure for thinking about adoption measurement across its full dimensionality.

6.2 A Practical Metrics Framework for Life Sciences Organizations

6.3 Connecting Adoption Metrics to Business Outcomes

The discipline of establishing metric connections upfront — before DAP deployment, as part of the business case development — is what separates organizations that sustain adoption investment from those that let it decay into a one-time implementation.

7. Risks, Ethics, and Change Management

7.1 The Human Side of Adoption

Digital adoption solutions are, fundamentally, tools for changing human behavior. The most technically sophisticated DAP deployment will underperform if users perceive the guidance layer as surveillance or additional complexity rather than simplification.

7.2 Accountability, Transparency, and the Governance of Guidance

In pharmaceutical and life sciences organizations, treating DAP content as a document type within the quality management system — with defined ownership, review cycles, and change control procedures — is both practical and defensible from a regulatory standpoint.

7.3 Selecting Partners for an Uncertain Integration Landscape

Evaluate DAP vendors not only on their current capabilities but on their integration strategy and ecosystem positioning. Vendors with formal partnership agreements with major enterprise software providers and platforms built with open APIs are better positioned for the transition ahead.

7.4 Where Is Your Organization on the Adoption Maturity Curve?

8. The Call to Build: A Message to Software Providers

8.1 The Argument in Plain Terms

Software providers face a straightforward strategic choice: continue to sell platforms that users struggle to learn, or take responsibility for the full arc of user value — from first login to deep proficiency — and build adoption intelligence into the product itself.

8.2 What We Are Asking Vendors to Consider

• First-run experience as a product priority. The first five hours of a user’s interaction with a new enterprise system are the most consequential for long-term adoption.
• Contextual help that knows the context. Users need dynamic assistance that understands where they are in a workflow and what they are likely trying to accomplish — achievable with current AI capabilities and should be a standard feature.
• Native analytics on user proficiency, not just feature usage. Building workflow-level proficiency analytics natively and surfacing them to both administrators and users enables proactive intervention at scale.
• Open APIs for DAP integration. Well-documented DAP integration APIs allow specialized adoption tools to function with the contextual intelligence of native integration.
• Adoption SLAs in enterprise contracts. The most forward-thinking vendors will move toward adoption outcome commitments, not just uptime SLAs.

8.3 What Buyers Can Do Now

Make adoption a procurement criterion. Invest in a DAP relationship with a strategic horizon — select a partner whose integration strategy aligns with your technology stack and whose product roadmap reflects investment in AI-driven personalization. Build internal adoption capability: the organizational muscle for managing digital adoption should not live only in the DAP vendor.

Conclusion

The case for digital adoption solutions is no longer a novel argument. The data is clear, the market is growing, and the business outcomes are documented. What remains contested is the question of where adoption capability should live — and that question has a right answer that the enterprise software industry has not yet fully embraced.

Digital adoption should be native to enterprise software. Not because standalone DAP platforms are failing — they are not. But because the structural limitations of the overlay model represent a ceiling on what is achievable. We have seen how the story ends with generative AI. We know what it looks like when software vendors stop treating a foundational capability as an optional add-on and build it into the product itself.

For pharmaceutical, biotech, and life sciences organizations, this shift matters more than in most sectors. The cost of poor adoption in your environment is also measured in data integrity exposure, compliance risk, deviation cycle time, and the quiet erosion of confidence in the AI-driven insights your platforms are expected to deliver. Getting users proficient — and keeping them there — must be a foundational product responsibility.

The call to software providers is straightforward: build adoption in. Make user proficiency a product commitment, not a customer problem. The market will reward the vendors who move first — and the organizations they serve will be better for it.

Sakara Digital advises life sciences and pharmaceutical organizations on digital transformation strategy, technology selection, and operational readiness for AI and advanced analytics. Contact us at sakaradigital.com.